Analysts expect CRISPR Therapeutics AG to report revenue of 10.23 M for Q4 26, against a range of 9.63 M to 10.82 M. The most recent reported quarter, Q3 26, came in at 12.67 M, a 11.9% miss against the 14.38 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 35.69 M | 865,000.00 | 892,000.00 | 889,000.00 | 864,000.00 | 1.46 M | 10.18 M | 12.67 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 8.65 M | 7.05 M | 6.32 M | 10.13 M | 5.39 M | 6.16 M | 7.52 M | 14.84 M | 10.82 M | 11.47 M | 10.79 M | 12.13 M | 30.49 M | 70.66 M | 140.95 M | 124.92 M | |||||||||
| Low Estimate | 7.08 M | 6.24 M | 5.17 M | 9.25 M | 4.66 M | 5.60 M | 6.57 M | 13.92 M | 9.63 M | 9.53 M | 9.77 M | 11.08 M | 26.49 M | 64.38 M | 125.44 M | 107.24 M | |||||||||
| Consensus Estimate | 7.87 M | 6.65 M | 5.74 M | 9.69 M | 5.03 M | 5.88 M | 7.04 M | 14.38 M | 10.23 M | 10.50 M | 10.28 M | 11.60 M | 28.49 M | 67.52 M | 133.20 M | 116.08 M |
Analysts expect CRISPR Therapeutics AG to report earnings per share of -1.27 for Q4 26, against a range of -1.37 to -1.17. The most recent reported quarter, Q3 26, came in at -1.15, a 3.6% miss against the -1.11 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.44 | -1.58 | -2.40 | -1.17 | -1.37 | -1.28 | -0.94 | -1.15 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -1.10 | -1.22 | -1.39 | -1.13 | -1.13 | -1.07 | -1.15 | -1.04 | -1.17 | -0.98 | -1.00 | -0.98 | -1.13 | -0.64 | -0.40 | -0.27 | |||||||||
| Low Estimate | -1.18 | -1.32 | -1.59 | -1.21 | -1.27 | -1.25 | -1.29 | -1.18 | -1.37 | -1.04 | -1.08 | -1.10 | -1.31 | -0.76 | -0.44 | -0.31 | |||||||||
| Consensus Estimate | -1.14 | -1.27 | -1.49 | -1.17 | -1.20 | -1.16 | -1.22 | -1.11 | -1.27 | -1.01 | -1.04 | -1.04 | -1.22 | -0.70 | -0.42 | -0.29 |
Pull Wall Street consensus for CRISPR Therapeutics AG (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CRSP&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CRSP", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CRSP&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();